5d 1m 3m 1y 5y 10y
There is research on this stock available only to PRO subscribers.
There are no Transcripts on LJPC.
Business Wire (Wed, 8:00AM)
Marketwire (Feb 12, 2014)
Marketwire (Feb 5, 2014)
Marketwire (Jan 13, 2014)
LJPC vs. ETF Alternatives
La Jolla Pharmaceutical Co. is a biopharmaceutical company engaged in the discovery, development and commercialization of therapeutics for chronic organ failure and cancer. It is engaged in the drug development of two products: GCS-100 and LJPC-501.